Persistence with denosumab therapy in women affected by osteoporosis with fragility fractures: a multicenter observational real practice study in Italy

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

Steven R. Cummings, Javier San Martín, Michael R. McClung et al. · New England Journal of Medicine · 2009 · 3.4K citations · Full text

Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial

Jacques P. Brown, Richard L. Prince, Chad Deal et al. · Journal of Bone and Mineral Research · 2008 · 595 citations

Total Hip, Gynecology, Pharmacotherapy +16

Comparing Adherence and Persistence Across 6 Chronic Medication Classes

Jason Yeaw, Joshua S. Benner, John G. Walt et al. · Journal of Managed Care Pharmacy · 2009 · 547 citations · Full text

Health-Related Quality of Life in Postmenopausal Women With Low BMD With or Without Prevalent Vertebral Fractures

Anna Oleksik, Paul Lips, Alison Dawson et al. · Journal of Bone and Mineral Research · 2000 · 510 citations

Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy

David L. Kendler, Christian Roux, Claude Laurent Benhamou et al. · Journal of Bone and Mineral Research · 2009 · 447 citations · Full text

Bone Disease, Adverse Events, Bone Health +14